ID   IPO43
AC   CVCL_C0Z8
SY   IPOLFG Serous Ovarian Carcinoma 43
DR   cancercelllines; CVCL_C0Z8
DR   Wikidata; Q114311749
RX   PubMed=35501869;
CC   Population: Caucasian.
CC   Doubling time: 37.3 hours (PubMed=35501869).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous (PubMed=35501869).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val172Phe (c.514G>T); ClinVar=VCV000428909; Zygosity=Heterozygous (PubMed=35501869).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=35501869
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 10,11
ST   Penta D: 12,13
ST   TH01: 9
ST   TPOX: 8,10
ST   vWA: 16,19
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
RX   PubMed=35501869; DOI=10.1186/s12935-022-02600-3; PMCID=PMC9063187;
RA   Silva F., Coelho F., Peixoto A., Pinto P., Martins C., Frombach A.-S.,
RA   Santo V.E., Brito C., Guimaraes A., Felix A.;
RT   "Establishment and characterization of a novel ovarian high-grade
RT   serous carcinoma cell line -- IPO43.";
RL   Cancer Cell Int. 22:175.1-175.17(2022).
//